Endovascular treatment of erectile dysfunction

Jonathan D. Paul, Jason H Rogers, Atman P. Shah, Sandeep Nathan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Erectile dysfunction (ED) refers to the persistent inability to achieve and maintain an erection adequate for sexual intercourse with a global prevalence in excess of 150 million and, left untreated, is widely recognized to decrease quality of life. Over one half of US males between the ages of 40 and 70 years report some degree of ED with the prevalence increasing with age and with the presence of cardiovascular risk factors such as smoking, diabetes mellitus, hyperlipidemia, and hypertension. ED may have numerous etiologies and its occurrence is often multifactorial with vasculogenic, hormonal, and emotional/psychological factors all contributing. As noted above, patients with ED frequently have cardiovascular risk factors or manifest cardiovascular disease, and indeed, many commonly prescribed pharmacotherapies for hypertension, heart disease, etc. can also promote ED. Prior pelvic trauma and central or peripheral neurologic disease may also be contributory. Despite the myriad factors listed however most ED ultimately is linked to a disorder of vascular structure or function and may relate to inadequate arterial flow, impaired cavernosal smooth muscle relaxation, or veno-occlusive dysfunction. It should be noted that given the coexistence of various contributory disease processes, evaluation and therapy for ED necessitate the coordinated, multidisciplinary efforts of urologists, vascular and sexual medicine specialists, and primary care physicians.

Original languageEnglish (US)
Title of host publicationEndovascular Interventions: A Case-Based Approach
PublisherSpringer New York
Pages1237-1246
Number of pages10
ISBN (Electronic)9781461473121
ISBN (Print)9781461473114
DOIs
StatePublished - Jan 1 2014

Fingerprint

Erectile Dysfunction
Therapeutics
Hypertension
Muscle Relaxation
Coitus
Central Nervous System Diseases
Primary Care Physicians
Peripheral Nervous System Diseases
Hyperlipidemias
Cardiology
Smooth Muscle
Blood Vessels
Heart Diseases
Diabetes Mellitus
Cardiovascular Diseases
Smoking
Quality of Life
Psychology
Drug Therapy
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Paul, J. D., Rogers, J. H., Shah, A. P., & Nathan, S. (2014). Endovascular treatment of erectile dysfunction. In Endovascular Interventions: A Case-Based Approach (pp. 1237-1246). Springer New York. https://doi.org/10.1007/978-1-4614-7312-1_102

Endovascular treatment of erectile dysfunction. / Paul, Jonathan D.; Rogers, Jason H; Shah, Atman P.; Nathan, Sandeep.

Endovascular Interventions: A Case-Based Approach. Springer New York, 2014. p. 1237-1246.

Research output: Chapter in Book/Report/Conference proceedingChapter

Paul, JD, Rogers, JH, Shah, AP & Nathan, S 2014, Endovascular treatment of erectile dysfunction. in Endovascular Interventions: A Case-Based Approach. Springer New York, pp. 1237-1246. https://doi.org/10.1007/978-1-4614-7312-1_102
Paul JD, Rogers JH, Shah AP, Nathan S. Endovascular treatment of erectile dysfunction. In Endovascular Interventions: A Case-Based Approach. Springer New York. 2014. p. 1237-1246 https://doi.org/10.1007/978-1-4614-7312-1_102
Paul, Jonathan D. ; Rogers, Jason H ; Shah, Atman P. ; Nathan, Sandeep. / Endovascular treatment of erectile dysfunction. Endovascular Interventions: A Case-Based Approach. Springer New York, 2014. pp. 1237-1246
@inbook{df0ef7be88eb4691a182909cb66e0e44,
title = "Endovascular treatment of erectile dysfunction",
abstract = "Erectile dysfunction (ED) refers to the persistent inability to achieve and maintain an erection adequate for sexual intercourse with a global prevalence in excess of 150 million and, left untreated, is widely recognized to decrease quality of life. Over one half of US males between the ages of 40 and 70 years report some degree of ED with the prevalence increasing with age and with the presence of cardiovascular risk factors such as smoking, diabetes mellitus, hyperlipidemia, and hypertension. ED may have numerous etiologies and its occurrence is often multifactorial with vasculogenic, hormonal, and emotional/psychological factors all contributing. As noted above, patients with ED frequently have cardiovascular risk factors or manifest cardiovascular disease, and indeed, many commonly prescribed pharmacotherapies for hypertension, heart disease, etc. can also promote ED. Prior pelvic trauma and central or peripheral neurologic disease may also be contributory. Despite the myriad factors listed however most ED ultimately is linked to a disorder of vascular structure or function and may relate to inadequate arterial flow, impaired cavernosal smooth muscle relaxation, or veno-occlusive dysfunction. It should be noted that given the coexistence of various contributory disease processes, evaluation and therapy for ED necessitate the coordinated, multidisciplinary efforts of urologists, vascular and sexual medicine specialists, and primary care physicians.",
author = "Paul, {Jonathan D.} and Rogers, {Jason H} and Shah, {Atman P.} and Sandeep Nathan",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-7312-1_102",
language = "English (US)",
isbn = "9781461473114",
pages = "1237--1246",
booktitle = "Endovascular Interventions: A Case-Based Approach",
publisher = "Springer New York",

}

TY - CHAP

T1 - Endovascular treatment of erectile dysfunction

AU - Paul, Jonathan D.

AU - Rogers, Jason H

AU - Shah, Atman P.

AU - Nathan, Sandeep

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Erectile dysfunction (ED) refers to the persistent inability to achieve and maintain an erection adequate for sexual intercourse with a global prevalence in excess of 150 million and, left untreated, is widely recognized to decrease quality of life. Over one half of US males between the ages of 40 and 70 years report some degree of ED with the prevalence increasing with age and with the presence of cardiovascular risk factors such as smoking, diabetes mellitus, hyperlipidemia, and hypertension. ED may have numerous etiologies and its occurrence is often multifactorial with vasculogenic, hormonal, and emotional/psychological factors all contributing. As noted above, patients with ED frequently have cardiovascular risk factors or manifest cardiovascular disease, and indeed, many commonly prescribed pharmacotherapies for hypertension, heart disease, etc. can also promote ED. Prior pelvic trauma and central or peripheral neurologic disease may also be contributory. Despite the myriad factors listed however most ED ultimately is linked to a disorder of vascular structure or function and may relate to inadequate arterial flow, impaired cavernosal smooth muscle relaxation, or veno-occlusive dysfunction. It should be noted that given the coexistence of various contributory disease processes, evaluation and therapy for ED necessitate the coordinated, multidisciplinary efforts of urologists, vascular and sexual medicine specialists, and primary care physicians.

AB - Erectile dysfunction (ED) refers to the persistent inability to achieve and maintain an erection adequate for sexual intercourse with a global prevalence in excess of 150 million and, left untreated, is widely recognized to decrease quality of life. Over one half of US males between the ages of 40 and 70 years report some degree of ED with the prevalence increasing with age and with the presence of cardiovascular risk factors such as smoking, diabetes mellitus, hyperlipidemia, and hypertension. ED may have numerous etiologies and its occurrence is often multifactorial with vasculogenic, hormonal, and emotional/psychological factors all contributing. As noted above, patients with ED frequently have cardiovascular risk factors or manifest cardiovascular disease, and indeed, many commonly prescribed pharmacotherapies for hypertension, heart disease, etc. can also promote ED. Prior pelvic trauma and central or peripheral neurologic disease may also be contributory. Despite the myriad factors listed however most ED ultimately is linked to a disorder of vascular structure or function and may relate to inadequate arterial flow, impaired cavernosal smooth muscle relaxation, or veno-occlusive dysfunction. It should be noted that given the coexistence of various contributory disease processes, evaluation and therapy for ED necessitate the coordinated, multidisciplinary efforts of urologists, vascular and sexual medicine specialists, and primary care physicians.

UR - http://www.scopus.com/inward/record.url?scp=84956639078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956639078&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7312-1_102

DO - 10.1007/978-1-4614-7312-1_102

M3 - Chapter

AN - SCOPUS:84956639078

SN - 9781461473114

SP - 1237

EP - 1246

BT - Endovascular Interventions: A Case-Based Approach

PB - Springer New York

ER -